Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(2.95)
# 1,371
Out of 5,152 analysts
885
Total ratings
39.63%
Success rate
0.29%
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LXRX Lexicon Pharmaceuticals | Maintains: Buy | $4 → $6 | $1.72 | +248.84% | 24 | Mar 5, 2026 | |
| QTTB Q32 Bio | Initiates: Buy | $13 | $4.27 | +204.45% | 1 | Feb 25, 2026 | |
| LGND Ligand Pharmaceuticals | Maintains: Buy | $231 → $239 | $201.00 | +18.91% | 23 | Feb 24, 2026 | |
| FBIO Fortress Biotech | Reiterates: Buy | $17 | $3.29 | +416.72% | 5 | Feb 23, 2026 | |
| ARMP Armata Pharmaceuticals | Maintains: Buy | $9 → $15 | $10.95 | +37.05% | 16 | Feb 23, 2026 | |
| ANL Adlai Nortye | Upgrades: Buy | $16 | $9.18 | +74.29% | 5 | Feb 13, 2026 | |
| APRE Aprea Therapeutics | Maintains: Buy | $5 → $4 | $0.92 | +332.48% | 16 | Jan 29, 2026 | |
| CALC CalciMedica | Downgrades: Neutral | n/a | $0.67 | - | 13 | Jan 29, 2026 | |
| TPST Tempest Therapeutics | Upgrades: Buy | $11 | $2.29 | +381.40% | 20 | Jan 22, 2026 | |
| KURA Kura Oncology | Reiterates: Buy | $40 | $8.76 | +356.62% | 29 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 → $310 | $254.68 | +21.72% | 35 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $136 | $59.94 | +126.89% | 51 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $2.32 | +417.24% | 1 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3 | $0.81 | +269.73% | 20 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $104 → $97 | $26.39 | +267.56% | 25 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $7 | $4.60 | +52.17% | 3 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $60 | $25.33 | +136.87% | 27 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.48 | +1,559.41% | 3 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $6 | $5.85 | +2.56% | 19 | Dec 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $47 | $26.53 | +77.16% | 6 | Nov 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $6.41 | +305.84% | 18 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 | $1.87 | +381.28% | 13 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $0.65 | +2,218.39% | 33 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $9 | $5.04 | +78.57% | 30 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $52 | $30.09 | +72.84% | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $28.56 | +99.58% | 27 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $102 | $32.40 | +214.81% | 35 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.17 | +2,036.75% | 17 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.73 | +486.08% | 30 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.83 | - | 26 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $4.16 | +260.58% | 17 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $42 | $29.24 | +43.64% | 36 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $30 | $30.47 | -1.54% | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $10 | $9.00 | +11.17% | 10 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.58 | - | 23 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $27.32 | +53.73% | 1 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.17 | +1,096.58% | 2 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.17 | +241.88% | 31 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $2.14 | +4,562.87% | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $3.07 | +95.44% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $2.62 | +892.37% | 14 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $280 | $2.47 | +11,236.03% | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $17 | $1.00 | +1,600.00% | 1 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $7.95 | +302.77% | 6 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $9 | $0.16 | +5,486.59% | 1 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $18 | $1.34 | +1,243.28% | 30 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $5.32 | +351.13% | 18 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.33 | - | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $5.41 | +472.50% | 31 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.63 | +1,801.14% | 1 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $15.34 | +141.20% | 17 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.88 | +486.67% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $22.26 | -68.55% | 29 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.89 | +2,695.48% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $0.91 | +10,916.86% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.49 | - | 6 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.14 | - | 2 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $28.61 | +15.34% | 2 | Nov 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $6.25 | +1,148.00% | 1 | Mar 24, 2017 |
Lexicon Pharmaceuticals
Mar 5, 2026
Maintains: Buy
Price Target: $4 → $6
Current: $1.72
Upside: +248.84%
Q32 Bio
Feb 25, 2026
Initiates: Buy
Price Target: $13
Current: $4.27
Upside: +204.45%
Ligand Pharmaceuticals
Feb 24, 2026
Maintains: Buy
Price Target: $231 → $239
Current: $201.00
Upside: +18.91%
Fortress Biotech
Feb 23, 2026
Reiterates: Buy
Price Target: $17
Current: $3.29
Upside: +416.72%
Armata Pharmaceuticals
Feb 23, 2026
Maintains: Buy
Price Target: $9 → $15
Current: $10.95
Upside: +37.05%
Adlai Nortye
Feb 13, 2026
Upgrades: Buy
Price Target: $16
Current: $9.18
Upside: +74.29%
Aprea Therapeutics
Jan 29, 2026
Maintains: Buy
Price Target: $5 → $4
Current: $0.92
Upside: +332.48%
CalciMedica
Jan 29, 2026
Downgrades: Neutral
Price Target: n/a
Current: $0.67
Upside: -
Tempest Therapeutics
Jan 22, 2026
Upgrades: Buy
Price Target: $11
Current: $2.29
Upside: +381.40%
Kura Oncology
Jan 13, 2026
Reiterates: Buy
Price Target: $40
Current: $8.76
Upside: +356.62%
Jan 9, 2026
Reiterates: Buy
Price Target: $240 → $310
Current: $254.68
Upside: +21.72%
Dec 22, 2025
Maintains: Buy
Price Target: $120 → $136
Current: $59.94
Upside: +126.89%
Dec 16, 2025
Initiates: Buy
Price Target: $12
Current: $2.32
Upside: +417.24%
Dec 12, 2025
Maintains: Buy
Price Target: $5 → $3
Current: $0.81
Upside: +269.73%
Dec 11, 2025
Maintains: Buy
Price Target: $104 → $97
Current: $26.39
Upside: +267.56%
Dec 5, 2025
Maintains: Buy
Price Target: $21 → $7
Current: $4.60
Upside: +52.17%
Dec 3, 2025
Maintains: Buy
Price Target: $24 → $60
Current: $25.33
Upside: +136.87%
Dec 2, 2025
Reiterates: Buy
Price Target: $8
Current: $0.48
Upside: +1,559.41%
Dec 1, 2025
Upgrades: Buy
Price Target: $6
Current: $5.85
Upside: +2.56%
Nov 28, 2025
Reiterates: Buy
Price Target: $47
Current: $26.53
Upside: +77.16%
Nov 26, 2025
Reiterates: Buy
Price Target: $26
Current: $6.41
Upside: +305.84%
Nov 24, 2025
Maintains: Buy
Price Target: $9
Current: $1.87
Upside: +381.28%
Nov 13, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $0.65
Upside: +2,218.39%
Oct 29, 2025
Maintains: Buy
Price Target: $20 → $9
Current: $5.04
Upside: +78.57%
Oct 20, 2025
Assumes: Buy
Price Target: $52
Current: $30.09
Upside: +72.84%
Oct 8, 2025
Reiterates: Buy
Price Target: $57
Current: $28.56
Upside: +99.58%
Sep 29, 2025
Reiterates: Buy
Price Target: $102
Current: $32.40
Upside: +214.81%
Sep 22, 2025
Reiterates: Buy
Price Target: $25
Current: $1.17
Upside: +2,036.75%
Sep 19, 2025
Reiterates: Buy
Price Target: $16
Current: $2.73
Upside: +486.08%
Sep 15, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.83
Upside: -
Aug 21, 2025
Reiterates: Buy
Price Target: $15
Current: $4.16
Upside: +260.58%
Aug 20, 2025
Maintains: Buy
Price Target: $50 → $42
Current: $29.24
Upside: +43.64%
Aug 5, 2025
Maintains: Buy
Price Target: $5 → $30
Current: $30.47
Upside: -1.54%
Aug 4, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $9.00
Upside: +11.17%
Jul 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.58
Upside: -
Jun 30, 2025
Initiates: Buy
Price Target: $42
Current: $27.32
Upside: +53.73%
Jun 25, 2025
Reiterates: Buy
Price Target: $14
Current: $1.17
Upside: +1,096.58%
Jun 24, 2025
Reiterates: Buy
Price Target: $4
Current: $1.17
Upside: +241.88%
Jun 18, 2025
Reiterates: Buy
Price Target: $100
Current: $2.14
Upside: +4,562.87%
Jun 17, 2025
Assumes: Buy
Price Target: $6
Current: $3.07
Upside: +95.44%
Jun 17, 2025
Reiterates: Buy
Price Target: $26
Current: $2.62
Upside: +892.37%
Jun 11, 2025
Reiterates: Buy
Price Target: $280
Current: $2.47
Upside: +11,236.03%
May 19, 2025
Assumes: Buy
Price Target: $17
Current: $1.00
Upside: +1,600.00%
May 16, 2025
Reiterates: Buy
Price Target: $32
Current: $7.95
Upside: +302.77%
May 8, 2025
Assumes: Buy
Price Target: $9
Current: $0.16
Upside: +5,486.59%
May 6, 2025
Maintains: Buy
Price Target: $40 → $18
Current: $1.34
Upside: +1,243.28%
Apr 21, 2025
Reiterates: Buy
Price Target: $24
Current: $5.32
Upside: +351.13%
Apr 9, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.33
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $31
Current: $5.41
Upside: +472.50%
Apr 3, 2025
Initiates: Buy
Price Target: $12
Current: $0.63
Upside: +1,801.14%
Mar 21, 2025
Reiterates: Buy
Price Target: $37
Current: $15.34
Upside: +141.20%
Mar 19, 2025
Reiterates: Buy
Price Target: $11
Current: $1.88
Upside: +486.67%
Feb 13, 2025
Maintains: Buy
Price Target: $17 → $7
Current: $22.26
Upside: -68.55%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $0.89
Upside: +2,695.48%
May 16, 2024
Reiterates: Buy
Price Target: $100
Current: $0.91
Upside: +10,916.86%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.49
Upside: -
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $1.14
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $28.61
Upside: +15.34%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $6.25
Upside: +1,148.00%